Announcement no. 1/2025

5 February 2025

Interim report Q4 2024

COPENHAGEN, Denmark, Feb. 5, 2025 /PRNewswire/ --

Sveinn Sölvason, President and CEO, comments:

"Sales in Q4 2024 amounted to USD 225 million, where our organic sales growth was 5% for the quarter and local currency growth was 8%. The continued strong momentum we have seen throughout the year in our Prosthetics & Neuro Orthotics business continued to drive our growth, supported by good growth contribution across all our regions. Bracing & Supports sales growth was modest for the quarter while sales in Patient Care declined, impacted by a strong comparison. For the full year 2024, our organic sales growth was 6%, driven by a strong performance in EMEA and our Prosthetics & Neuro Orthotics and Patient Care segments.

Announcement no. 1/2025

5 February 2025

Interim report Q4 2024

COPENHAGEN, Denmark, Feb. 5, 2025 /PRNewswire/ --

Sveinn Sölvason, President and CEO, comments:

"Sales in Q4 2024 amounted to USD 225 million, where our organic sales growth was 5% for the quarter and local currency growth was 8%. The continued strong momentum we have seen throughout the year in our Prosthetics & Neuro Orthotics business continued to drive our growth, supported by good growth contribution across all our regions. Bracing & Supports sales growth was modest for the quarter while sales in Patient Care declined, impacted by a strong comparison. For the full year 2024, our organic sales growth was 6%, driven by a strong performance in EMEA and our Prosthetics & Neuro Orthotics and Patient Care segments.

Announcement no. 12/2024

Interim report Q3 2024

22 October 2024

COPENHAGEN, Denmark, Oct. 22, 2024 /PRNewswire/ -- 

Sveinn Sölvason, President and CEO, comments:

"We delivered solid sales in the third quarter amounting to USD 214 million. Organic sales growth was 7% and local currency growth was 11%. The strong momentum we have seen in EMEA throughout 2024 continued driven by strong performance in Prosthetics & Neuro Orthotics and Patient Care. In our Bracing & Supports business growth was more modest for the quarter.

Announcement no. 12/2024

Interim report Q3 2024

22 October 2024

COPENHAGEN, Denmark, Oct. 22, 2024 /PRNewswire/ -- 

Sveinn Sölvason, President and CEO, comments:

"We delivered solid sales in the third quarter amounting to USD 214 million. Organic sales growth was 7% and local currency growth was 11%. The strong momentum we have seen in EMEA throughout 2024 continued driven by strong performance in Prosthetics & Neuro Orthotics and Patient Care. In our Bracing & Supports business growth was more modest for the quarter.

Össur Athletes Also Set 5 New Paralympic Records While Wearing "Gold Standard" Cheetah Prosthetic Blades

REYKJAVIK, Iceland, Sept. 11, 2024 /PRNewswire/ --  A global team of elite para athletes who wear Össur's renowned prosthetics won 22 medals and set five new Paralympic Records during the 2024 Paralympic Games in Paris, with the company's iconic carbon fiber Cheetah sports blades, easily identified by their distinctive yellow stripe, dominating several categories of Athletics competition. Össur is a leading global prosthetic brand belonging to mobility solutions provider Embla Medical.

Össur Athletes Also Set 5 New Paralympic Records While Wearing "Gold Standard" Cheetah Prosthetic Blades

REYKJAVIK, Iceland, Sept. 11, 2024 /PRNewswire/ --  A global team of elite para athletes who wear Össur's renowned prosthetics won 22 medals and set five new Paralympic Records during the 2024 Paralympic Games in Paris, with the company's iconic carbon fiber Cheetah sports blades, easily identified by their distinctive yellow stripe, dominating several categories of Athletics competition. Össur is a leading global prosthetic brand belonging to mobility solutions provider Embla Medical.